Literature DB >> 2121692

Purification and characterization of tumor invasion-inhibiting factors.

A Isoai1, Y Giga-Hama, K Shinkai, M Mukai, H Akedo, H Kumagai.   

Abstract

Tumor invasion-inhibiting factors were purified from bovine liver using an in vitro system for estimating the tumor invasion ability. The acid-ethanol extract of liver was subjected to ultrafiltration (Amicon PM10 membrane), and the fraction corresponding to the molecular weight range below 10,000 was further fractionated by ion-exchange (DEAE-Toyopearl), gel filtration (Bio-Gel P6), and reverse-phase (C18) chromatographies. Two types of active polypeptides with molecular weights of about 5,000 and 2,000 were purified and named IIF-1 and IIF-2, respectively. Both peptides inhibited tumor invasion with half-maximum concentrations of 2-6 ng/ml in vitro. The amino acid compositions of both peptides were determined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121692      PMCID: PMC5918113          DOI: 10.1111/j.1349-7006.1990.tb02666.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  10 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade.

Authors:  P Mignatti; E Robbins; D B Rifkin
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

Review 3.  The biology of cancer invasion and metastasis.

Authors:  I J Fidler; D M Gersten; I R Hart
Journal:  Adv Cancer Res       Date:  1978       Impact factor: 6.242

4.  Inhibition of proteolytic enzymes in the in vitro amnion model for basement membrane invasion.

Authors:  B Persky; L E Ostrowski; P Pagast; A Ahsan; R M Schultz
Journal:  Cancer Res       Date:  1986-08       Impact factor: 12.701

Review 5.  Tumor invasion and the extracellular matrix.

Authors:  L A Liotta; C N Rao; S H Barsky
Journal:  Lab Invest       Date:  1983-12       Impact factor: 5.662

6.  Metastatic potential correlates with enzymatic degradation of basement membrane collagen.

Authors:  L A Liotta; K Tryggvason; S Garbisa; I Hart; C M Foltz; S Shafie
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

7.  Superoxide radical potentiates invasive capacity of rat ascites hepatoma cells in vitro.

Authors:  K Shinkai; M Mukai; H Akedo
Journal:  Cancer Lett       Date:  1986-07       Impact factor: 8.679

8.  Factor from rat liver with antiinvasive potential on rat ascites hepatoma cells.

Authors:  K Shinkai; M Mukai; K Komatsu; H Akedo
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

Review 9.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

10.  Interaction of rat ascites hepatoma cells with cultured mesothelial cell layers: a model for tumor invasion.

Authors:  H Akedo; K Shinkai; M Mukai; Y Mori; R Tateishi; K Tanaka; R Yamamoto; T Morishita
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

  10 in total
  7 in total

Review 1.  Technical considerations for studying cancer metastasis in vivo.

Authors:  D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

Review 2.  Current and future strategies to block tumor angiogenesis, invasion, and metastasis.

Authors:  P J Effert; G Gastl; T Strohmeyer
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 3.  HMGNs, DNA repair and cancer.

Authors:  Gabi Gerlitz
Journal:  Biochim Biophys Acta       Date:  2009-12-08

4.  Invasion-inhibiting factor 2-albumin conjugate inhibits invasion and spontaneous metastasis of MKL-4 human breast cancer cells transplanted into female nude mice.

Authors:  J Kurebayashi; M Kurosumi; A Isoai; R B Dickson; H Sonoo
Journal:  Clin Exp Metastasis       Date:  1996-03       Impact factor: 5.150

5.  Enhanced paracellular barrier function of rat mesothelial cells partially protects against cancer cell penetration.

Authors:  H Tobioka; N Sawada; Y Zhong; M Mori
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

6.  Serum requirement for in vitro invasion by tumor cells.

Authors:  F Imamura; T Horai; M Mukai; K Shinkai; H Akedo
Journal:  Jpn J Cancer Res       Date:  1991-05

7.  Exogenous HMGN2 inhibits the migration and invasion of osteosarcoma cell lines.

Authors:  Enjie Xu; Heng Jiang; Tao Lin; Yichen Meng; Xiao Ma; Jia Yin; Jun Ma; Xuhui Zhou
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.